BioCentury | Apr 22, 2019
Distillery Therapeutics

Combined inhibition of EGFR and RAF1 for mutant-KRAS, mutant TP53-driven PDAC

...M. et al. Cancer Cell ; published online Apr. 8, 2019 doi:10.1016/j.ccell.2019.03.002 CONTACT: Carmen Guerra, Spanish National Cancer Research Centre (CNIO)...
...CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Sandi Wong Ramon and Cajal Institute of Sanitary Research Spanish National Cancer Research Centre (CNIO) Epidermal...
BioCentury | Feb 7, 2018
Distillery Therapeutics

Cancer

...Musteanu, Spanish National Cancer Research Centre (CNIO), Madrid, Spain email: mmusteanu@cnio.es CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Hongjiang Li Spanish National Cancer Research Centre (CNIO) CRAF...
BioCentury | Jan 23, 2018
Distillery Therapeutics

Cancer

...Guerra, Spanish National Cancer Research Centre (CNIO), Madrid, Spain email: mcguerra@cnio.es CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Hongjiang Li Spanish National Cancer Research Centre (CNIO) Serum...
BioCentury | Jul 11, 2017
Preclinical News

Researchers link PLK1 inhibition to CV risks

...In a paper published in Nature Medicine , researchers at the Spanish National Cancer Research Centre (CNIO) identified an unexpected cardiovascular...
...its development. Mary Romeo TKM-PLK1 volasertib Arbutus Biopharma Corp. Boehringer Ingelheim GmbH Changzhou Le Sun Pharmaceuticals Ltd. Nerviano Medical Sciences s.r.l. Onconova Therapeutics Inc. Spanish National Cancer Research Centre (CNIO) Polo-like...
BioCentury | Mar 17, 2016
Strategy

Transcending TransCelerate

...Moores University; Lhasa Ltd.; Mar Institute of Medical Research Foundation (IMIM); Polytechnic University of Valencia; Spanish National Cancer Research Centre (CNIO)...
BioCentury | Feb 18, 2016
Distillery Therapeutics

Therapeutics: Discoidin domain receptor tyrosine kinase 1 (DDR1); Notch pathway; K-Ras (KRAS)

...Ambrogio, C. et al. Nat. Med.; published online Feb. 8, 2016 doi:10.1038/nm.4041 CONTACT: Chiara Ambrogio, Spanish National Cancer Research Centre (CNIO)...
BioCentury | Feb 11, 2016
Distillery Techniques

Techniques: Cyclin-dependent kinase inhibitor 1A (p21, Cip1)(CDKN1A; CIP1) and ribosomal protein S6 (RPS6) as prognostic markers in head and neck squamous cell

...Biomarkers RPS6 Cyclin-dependent kinase inhibitor 1A p21, Cip1 CDKN1A CIP1 ribosomal protein S6 (RPS6) Spanish National Cancer Research Centre (CNIO) BC Staff...
BioCentury | Aug 6, 2015
Distillery Techniques

Techniques: Two telomere dysfunction-driven mouse models of idiopathic pulmonary fibrosis (IPF)

...J. et al. Cell Rep.; published online July 2, 2015 doi:10.1016/j.celrep.2015.06.028 CONTACT: Maria A. Blasco, Spanish National Cancer Research Centre (CNIO)...
BioCentury | Apr 23, 2015
Distillery Therapeutics

Therapeutics: Phosphoinositide 3-kinase (PI3K)

...Ortega-Molina, A. et al. Cell Metab.; published online Mar. 26, 2015 doi:10.1016/j.cmet.2015.02.017 CONTACT: Manuel Serrano, Spanish National Cancer Research Centre (CNIO)...
BioCentury | Dec 11, 2014
Distillery Therapeutics

Indication: Cancer

...Tummala, K.S. et al. Cancer Cell; published online Nov. 20, 2014; doi:10.1016/j.ccell.2014.10.002 Contact: Nabil Djouder, Spanish National Cancer Research Centre (CNIO)...
Items per page:
1 - 10 of 23
BioCentury | Apr 22, 2019
Distillery Therapeutics

Combined inhibition of EGFR and RAF1 for mutant-KRAS, mutant TP53-driven PDAC

...M. et al. Cancer Cell ; published online Apr. 8, 2019 doi:10.1016/j.ccell.2019.03.002 CONTACT: Carmen Guerra, Spanish National Cancer Research Centre (CNIO)...
...CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Sandi Wong Ramon and Cajal Institute of Sanitary Research Spanish National Cancer Research Centre (CNIO) Epidermal...
BioCentury | Feb 7, 2018
Distillery Therapeutics

Cancer

...Musteanu, Spanish National Cancer Research Centre (CNIO), Madrid, Spain email: mmusteanu@cnio.es CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Hongjiang Li Spanish National Cancer Research Centre (CNIO) CRAF...
BioCentury | Jan 23, 2018
Distillery Therapeutics

Cancer

...Guerra, Spanish National Cancer Research Centre (CNIO), Madrid, Spain email: mcguerra@cnio.es CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Hongjiang Li Spanish National Cancer Research Centre (CNIO) Serum...
BioCentury | Jul 11, 2017
Preclinical News

Researchers link PLK1 inhibition to CV risks

...In a paper published in Nature Medicine , researchers at the Spanish National Cancer Research Centre (CNIO) identified an unexpected cardiovascular...
...its development. Mary Romeo TKM-PLK1 volasertib Arbutus Biopharma Corp. Boehringer Ingelheim GmbH Changzhou Le Sun Pharmaceuticals Ltd. Nerviano Medical Sciences s.r.l. Onconova Therapeutics Inc. Spanish National Cancer Research Centre (CNIO) Polo-like...
BioCentury | Mar 17, 2016
Strategy

Transcending TransCelerate

...Moores University; Lhasa Ltd.; Mar Institute of Medical Research Foundation (IMIM); Polytechnic University of Valencia; Spanish National Cancer Research Centre (CNIO)...
BioCentury | Feb 18, 2016
Distillery Therapeutics

Therapeutics: Discoidin domain receptor tyrosine kinase 1 (DDR1); Notch pathway; K-Ras (KRAS)

...Ambrogio, C. et al. Nat. Med.; published online Feb. 8, 2016 doi:10.1038/nm.4041 CONTACT: Chiara Ambrogio, Spanish National Cancer Research Centre (CNIO)...
BioCentury | Feb 11, 2016
Distillery Techniques

Techniques: Cyclin-dependent kinase inhibitor 1A (p21, Cip1)(CDKN1A; CIP1) and ribosomal protein S6 (RPS6) as prognostic markers in head and neck squamous cell

...Biomarkers RPS6 Cyclin-dependent kinase inhibitor 1A p21, Cip1 CDKN1A CIP1 ribosomal protein S6 (RPS6) Spanish National Cancer Research Centre (CNIO) BC Staff...
BioCentury | Aug 6, 2015
Distillery Techniques

Techniques: Two telomere dysfunction-driven mouse models of idiopathic pulmonary fibrosis (IPF)

...J. et al. Cell Rep.; published online July 2, 2015 doi:10.1016/j.celrep.2015.06.028 CONTACT: Maria A. Blasco, Spanish National Cancer Research Centre (CNIO)...
BioCentury | Apr 23, 2015
Distillery Therapeutics

Therapeutics: Phosphoinositide 3-kinase (PI3K)

...Ortega-Molina, A. et al. Cell Metab.; published online Mar. 26, 2015 doi:10.1016/j.cmet.2015.02.017 CONTACT: Manuel Serrano, Spanish National Cancer Research Centre (CNIO)...
BioCentury | Dec 11, 2014
Distillery Therapeutics

Indication: Cancer

...Tummala, K.S. et al. Cancer Cell; published online Nov. 20, 2014; doi:10.1016/j.ccell.2014.10.002 Contact: Nabil Djouder, Spanish National Cancer Research Centre (CNIO)...
Items per page:
1 - 10 of 23